What is Trajenta?

Category: Prescription Drugs


Generic name: Linagliptin

Trajenta® is an international brand name for linagliptin, an oral antidiabetic agent use in the treatment of noninsulin dependent diabetes as an adjunct to diet and exercise as a single agent or in combination therapy with other antidiabetic agents.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 1
Mild 0
None 3

Commonly reported side effects and conditions associated with Trajenta

Side effect Patients
Low blood sugar (hypoglycemia) 1


Based on patients currently taking Trajenta

Dosage Patients
5 mg daily 2

Why patients stopped taking Trajenta

Multiple reasons could be selected

Reason Patients
Doctor's advice 1
See 1 patient who's stopped taking Trajenta


Currently taking Trajenta

Duration Patients
2 - 5 years 2

Stopped taking Trajenta

Duration Patients
5 - 10 years 1
Adherence Evaluations
Always 3
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 4

What people switch to and from

Patients stopped taking Trajenta and switched to:

Treatment Patients
Liraglutide (Victoza) 1
Last updated:
There are no evaluations for Trajenta.